Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q3 2025 (September 30)5holders −1
1new positions
1sold out
$3.79avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were GAMMA Investing LLC ($175K), Fulton Bank, N.A. ($53K) and Rhumbline Advisers ($17K).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 1 | $79 |
All 13F filers, Q2 2025 → Q3 2025: 6,172 shares bought and 13,011 shares sold, net −6,839 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| GAMMA Investing LLC | 0.01% | Add +2.2% | 46,305 | $175K |
| Fulton Bank, N.A. | 0.00% | Add +11.3% | 13,855 | $53K |
| Rhumbline Advisers | 0.00% | Reduce -74.0% | 4,573 | $17K |
| Westside Investment Management, Inc. | 0.00% | New | 3,747 | $14K |
| Salomon & Ludwin, LLC | 0.00% | No change | 31 | $118 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.